ATE103185T1 - Stabilisierung von biologischen und pharmazeutischen produkten waehrend der inaktivierung von viralen und bakteriellen keimen. - Google Patents

Stabilisierung von biologischen und pharmazeutischen produkten waehrend der inaktivierung von viralen und bakteriellen keimen.

Info

Publication number
ATE103185T1
ATE103185T1 AT88108131T AT88108131T ATE103185T1 AT E103185 T1 ATE103185 T1 AT E103185T1 AT 88108131 T AT88108131 T AT 88108131T AT 88108131 T AT88108131 T AT 88108131T AT E103185 T1 ATE103185 T1 AT E103185T1
Authority
AT
Austria
Prior art keywords
biological
viral
stabilization
pharmaceutical products
aqueous solution
Prior art date
Application number
AT88108131T
Other languages
English (en)
Inventor
Fred Feldman
Mark S Klekamp
Michael E Hrinda
Arthur B Shaw
Sudhish Chandra
Original Assignee
Armour Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma Prod filed Critical Armour Pharma Prod
Application granted granted Critical
Publication of ATE103185T1 publication Critical patent/ATE103185T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT88108131T 1987-05-22 1988-05-20 Stabilisierung von biologischen und pharmazeutischen produkten waehrend der inaktivierung von viralen und bakteriellen keimen. ATE103185T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5292687A 1987-05-22 1987-05-22
EP88108131A EP0292003B1 (de) 1987-05-22 1988-05-20 Stabilisierung von biologischen und pharmazeutischen Produkten während der Inaktivierung von viralen und bakteriellen Keimen

Publications (1)

Publication Number Publication Date
ATE103185T1 true ATE103185T1 (de) 1994-04-15

Family

ID=21980809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88108131T ATE103185T1 (de) 1987-05-22 1988-05-20 Stabilisierung von biologischen und pharmazeutischen produkten waehrend der inaktivierung von viralen und bakteriellen keimen.

Country Status (11)

Country Link
EP (1) EP0292003B1 (de)
JP (2) JP2605102B2 (de)
AT (1) ATE103185T1 (de)
AU (1) AU606159B2 (de)
CA (1) CA1337688C (de)
DE (1) DE3888571T2 (de)
ES (1) ES2061554T3 (de)
FI (1) FI95778C (de)
IL (1) IL86417A (de)
NO (1) NO176234C (de)
NZ (1) NZ224740A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3619565A1 (de) * 1986-06-11 1987-12-17 Behringwerke Ag Verfahren zur herstellung einer pasteurisierten immunglobulinpraeparation
EP0440509A3 (en) * 1990-02-02 1991-12-18 Common Services Agency Novel cell growth medium components and process for producing same
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
WO1994013329A1 (de) * 1992-12-16 1994-06-23 Immuno Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
HRP940645A2 (en) * 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
CN101810854A (zh) 1999-02-22 2010-08-25 巴克斯特国际公司 新的无白蛋白的因子viii制剂
BRPI0611251A2 (pt) * 2005-06-06 2010-12-07 Novo Nordisk As composição, métodos para estabilizar uma composição compreendendo il-21, para redobrar il-21 não dobrada ou parcialmente dobrada em solução, para purificar il-21 e para tratar cáncer, e, uso de il-21 e sulfato
DE102006008613A1 (de) 2006-02-24 2007-08-30 Dade Behring Marburg Gmbh Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung
JP5779780B2 (ja) 2008-11-07 2015-09-16 バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated 第viii因子製剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53142593A (en) * 1977-12-12 1978-12-12 Green Cross Corp:The Stabilization of urokinase by heating
EP0035204B2 (de) * 1980-03-05 1991-05-22 Miles Inc. Pasteurisierte therapeutisch aktive Proteinzusammensetzungen
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第7因子含有水溶液の加熱処理方法
US4379085A (en) * 1982-05-14 1983-04-05 American National Red Cross Heat stabilization of plasma proteins
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
JPS59134730A (ja) * 1983-01-20 1984-08-02 Green Cross Corp:The 血液凝固第8因子の加熱処理法
CA1213827A (en) * 1983-04-29 1986-11-12 Ricardo H. Landaburu Process for pasteurizing fibronectin
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPS61189228A (ja) * 1985-02-19 1986-08-22 Nippon Sekijiyuujishiya 血液凝固第8因子製剤の製法
JPH0825902B2 (ja) * 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
JPS6289628A (ja) * 1985-09-11 1987-04-24 Green Cross Corp:The 人フイブリノゲン製剤の加熱処理法
JPS6281327A (ja) * 1985-10-04 1987-04-14 Green Cross Corp:The 人トロンビン製剤の加熱処理方法

Also Published As

Publication number Publication date
IL86417A (en) 1992-09-06
DE3888571D1 (de) 1994-04-28
JP2879427B2 (ja) 1999-04-05
NO176234C (no) 1995-03-01
AU1664288A (en) 1988-11-24
CA1337688C (en) 1995-12-05
EP0292003B1 (de) 1994-03-23
FI882387A (fi) 1988-11-23
ES2061554T3 (es) 1994-12-16
NO882242D0 (no) 1988-05-20
NZ224740A (en) 1990-01-29
IL86417A0 (en) 1988-11-15
JPS649937A (en) 1989-01-13
EP0292003A2 (de) 1988-11-23
NO176234B (no) 1994-11-21
JP2605102B2 (ja) 1997-04-30
EP0292003A3 (en) 1990-06-13
AU606159B2 (en) 1991-01-31
DE3888571T2 (de) 1994-08-11
FI95778B (fi) 1995-12-15
FI882387A0 (fi) 1988-05-20
FI95778C (fi) 1996-03-25
NO882242L (no) 1988-11-23
JPH09118634A (ja) 1997-05-06

Similar Documents

Publication Publication Date Title
ATE235262T1 (de) Verfahren zum sterilisieren von produkten
ATE103185T1 (de) Stabilisierung von biologischen und pharmazeutischen produkten waehrend der inaktivierung von viralen und bakteriellen keimen.
EP0128610A3 (de) Sterilisierungs- und Stabilisierungsverfahren für Lebensmittel bestehend aus Fleisch und/oder Fleischsurrogat
PT88591A (pt) Process for preparing a pharmaceutical composition substantially free from live viruses or bacteria
ATE72127T1 (de) Sterilisationsverfahren.
SE8803071D0 (sv) Bakteriebehandling for att bevara hokvalitet genom att tillegga genius bacillus mikroorganismer
CA2134535A1 (en) Method for sterilizing recombinant human serum albumin pharmaceutical preparation
EP0247998A3 (en) Process for the inactivation of propagating filtrable pathogenic microbes
AU568849B2 (en) Inactivation of viruses in virus containing protein samples
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
AU3876793A (en) Process for the inactivation of viruses in preparations of proteins
GR3017807T3 (en) Method for inactivating biological activity of DNA.
DE3574675D1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.
ATE269110T1 (de) Verfahren zur desinfektion von knochengeweben
ATE135921T1 (de) Verfahren zur sterilisation von chirurgischem material
AU7408787A (en) A process for the preparation of a pasteurized immunoglobulin preparation
ES8608892A1 (es) Procedimiento para esterilizar materiales de envasado para el envasado aseptico de zumo de frutas y de vino

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time